2 0 2 6 A n n u a l G e n e r a l M e e t i n g 2 October 2026 ASX Announcement PAGE 1 OF 15 Dear Shareholder, On behalf of your Board of Directors, I am pleased to invite you to the 2026 Annual General Meeting (AGM) of CLINUVEL PHARMACEUTICALS LIMITED (CUV or Company), to be held on Friday 6...
Clinuvel Pharmaceuticals: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 18 pages · English
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings CallRelease
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- New CUV105 vitiligo cases presented to EADV
- Becoming a substantial holder
- CLINUVEL date of Annual General Meeting
- CLINUVEL develops proprietary ZEROKIN device
- Ceasing to be a substantial holder
Later from Clinuvel Pharmaceuticals
- Change in substantial holding
- Application for quotation of securities - CUV
- Notification of cessation of securities - CUV
- Section 708A Cleansing Statement
- CLINUVEL files NEURACTHEL Instant dossier
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals